Expired activity
Please go to the PowerPak
homepage and select a course.
The “Rights” of Medication Therapy and Administration in Obesity Management
This activity is supported by an educational grant from Novo Nordisk.
Release Date
March 31, 2022
Expiration Date
March 31, 2023
Activity Overview and Format
- This activity is designed to provide pertinent specific information on safe administration, dosing, titration, and adverse event (AE) monitoring for anti-obesity medications, particularly injectable formulations, in a succinct format with wide reach
- This online interactive monograph includes a combination of written content with supporting figures, interactive knowledge and competency assessments, and downloadable resources
- The downloadable pharmacist resource includes summaries of key points highlighting important takeaways concerning safe usage, dosing, titration, and administration of anti-obesity medications, particularly injectable medications
- The downloadable patient resource emphasizes the importance of safe administration and titration, how to correctly inject and titrate doses of injectable medications, and recognition of AE concerns signaling required contact with the healthcare provider (HCP)
Faculty
Lindsay Curtin, PharmD, BCPS - Program Chair
Clinical Staff Pharmacist
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania
United States
Daniel E. Hilleman, PharmD
Professor
School of Pharmacy and Health Professions
Omaha, Nebraska
United States
Intended Audience
This activity is intended for pharmacists who dispense obesity medications.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Identify patients for whom obesity pharmacotherapy is recommended/indicated
- Discuss individual profiles of approved anti-obesity agents, including indications, dosing, administration, tolerability, and safety considerations
- Advise patients on effective storage, injection, and dose titration techniques and procedures for injectable anti-obesity medications
- Recognize when it is appropriate to delay titration, down-titrate, or discontinue anti-obesity medication
Accreditation and Credit Designation Statement
Pharmacists
Center for Independent Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education. Center has assigned 1.0 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.
ACPE UAN: 0473-9999-22-001-H01-P
Activity Type: Knowledge-based
Fee: There is no fee to participate in this activity.
Disclosures
Center for Independent Healthcare Education and IMNE fully comply with the Standards for Integrity and Independence in Accredited Continuing Education in development of CME/CPE activities. We require the full disclosure of financial relationships with ineligible companies from all individuals in a position to influence the content of a certified activity, in any amount occurring within the past 24 months. Each relevant financial relationship is identified by the provider and mitigated to prevent inserting commercial bias into content. All identified relevant financial relationships are disclosed to the learners prior to the activity. The faculty is further required to disclose of off-label uses in their presentations.
Documentation regarding this mitigation strategy is available by contacting Steve Weinman at 609 377 1030 or steve.weinman@imne.com.
For questions regarding pharmacy certification of this activity, please contact info@jointsponsor.com.
Resolutions of conflict of interest have been made in the form of external peer review.
The following disclosures have been made:
Faculty
Lindsay Curtin, PharmD, BCPS
Dr Curtin has nothing to disclose.
Dr Curtin does not discuss off-label uses of any products.
Daniel E. Hilleman, PharmD
Dr Hilleman has nothing to disclose.
Dr Hilleman does not discuss off-label uses of any products.
IMNE Staff
Amy Groves, BS (With Honors)
Business Lead
Ms Groves has nothing to disclose.
Steve Weinman, MSc, RN
Director of Accreditation
ANCC Accredited Provider Program Director
Mr Weinman has nothing to disclose.
Michelle Fisher, BS
Account Coordinator
Ms Fisher has nothing to disclose.
Katie Bickford
Medical Writer
Ms Bickford has nothing to disclose.
Ruth Wills
Editorial Team Leader
Ms Wills has nothing to disclose.
CPE Reviewer
Vesna Drenovac, RPh, MSc, CHCP
Ms Drenovac has nothing to disclose.
Mitigation of Conflicts of Interest
Center and IMNE use a peer review process to mitigate potential and actual conflicts of interest disclosed by all persons in a position to influence the planning process or content development of this educational activity. All peer reviewers are without relevant financial relationships. All relevant financial relationships have been mitigated.
Disclaimer
This activity is designed for HCPs for educational purposes. Information and opinions offered by the faculty/presenters represent their own viewpoints. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information.
While Center and IMNE make every effort to have accurate information presented, no warranty, expressed or implied, is offered. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Privacy and Confidentiality Statement
Center and IMNE will record learners’ personal information as provided on CPE evaluations to allow for issuance and tracking of CPE certificates. Center and IMNE may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CPE program. No individual performance data or other personal information collected from evaluations will be shared with third parties.
Method of Participation
To receive a maximum of 1.0 CPE Credits, participants should note the following:
- Complete the pretest
- Review all of the CPE information, including intended audience, learning objectives, disclosures, and the content in its entirety
- To claim CPE credit, you must complete the posttest with a score of ≥80% and then complete the activity evaluation form
- Pharmacy credit will be entered into the NABP CPE Monitor within 30 days
Minimum System Requirements
Please ensure the computer system you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Peripherals: Computer speakers or headphones
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5
